These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9876570)

  • 21. In vitro release of colchicine using poly(phosphazenes): the development of delivery systems for musculoskeletal use.
    Ibim SM; el-Amin SF; Goad ME; Ambrosio AM; Allcock HR; Laurencin CT
    Pharm Dev Technol; 1998 Feb; 3(1):55-62. PubMed ID: 9532600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Materials and biological aspects of synthetic polymers in controlled drug release systems: problems and challenges.
    Bruck SD; Mueller EP
    Crit Rev Ther Drug Carrier Syst; 1988; 5(3):171-87. PubMed ID: 3060266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Recent trends in drug delivery systems using biomaterials].
    Kurisawa M; Yui N
    Nihon Rinsho; 1996 Jul; 54(7):2004-11. PubMed ID: 8741703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microchips and controlled-release drug reservoirs.
    Staples M
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(4):400-17. PubMed ID: 20564466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro and in vivo demonstration of risperidone implants in mice.
    Rabin C; Liang Y; Ehrlichman RS; Budhian A; Metzger KL; Majewski-Tiedeken C; Winey KI; Siegel SJ
    Schizophr Res; 2008 Jan; 98(1-3):66-78. PubMed ID: 17765477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Programmable biodegradable implants.
    Vogelhuber W; Rotunno P; Magni E; Gazzaniga A; Spruss T; Bernhardt G; Buschauer A; Göpferich A
    J Control Release; 2001 May; 73(1):75-88. PubMed ID: 11337061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymer-based biodegradable drug delivery systems in pain management.
    Al Malyan M; Becchi C; Nikkola L; Viitanen P; Boncinelli S; Chiellini F; Ashammakhi N
    J Craniofac Surg; 2006 Mar; 17(2):302-13. PubMed ID: 16633180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthetic, implantable, biodegradable polymers for controlled release of radiosensitizers.
    Yuan X; Fahlman C; Tabassi K; Williams JA
    Cancer Biother Radiopharm; 1999 Jun; 14(3):177-86. PubMed ID: 10850302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioabsorbable polymers in medicine: an overview.
    Vert M
    EuroIntervention; 2009 Dec; 5 Suppl F():F9-F14. PubMed ID: 22100685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biocompatibility of implantable synthetic polymeric drug carriers: focus on brain biocompatibility.
    Fournier E; Passirani C; Montero-Menei CN; Benoit JP
    Biomaterials; 2003 Aug; 24(19):3311-31. PubMed ID: 12763459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of an in vitro dissolution method using microdialysis sampling technique for implantable drug delivery systems.
    Dash AK; Haney PW; Garavalia MJ
    J Pharm Sci; 1999 Oct; 88(10):1036-40. PubMed ID: 10514352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Bioabsorbable osteofixation devices].
    Iera D; Haddad AJ; Sándor GK; Ashmmakhi N
    Ann Chir Plast Esthet; 2005 Dec; 50(6):723-32. PubMed ID: 16181721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nano, micro particulate and cosmetic delivery systems of polylactic acid: A mini review.
    Abu Hajleh MN; Al-Samydai A; Al-Dujaili EAS
    J Cosmet Dermatol; 2020 Nov; 19(11):2805-2811. PubMed ID: 32954588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implantable, polymeric systems for modulated drug delivery.
    Sershen S; West J
    Adv Drug Deliv Rev; 2002 Nov; 54(9):1225-35. PubMed ID: 12393303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implantable systems for drug delivery to the brain.
    Kaurav H; Kapoor DN
    Ther Deliv; 2017 Dec; 8(12):1097-1107. PubMed ID: 29125063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic applications of implantable drug delivery systems.
    Dash AK; Cudworth GC
    J Pharmacol Toxicol Methods; 1998 Jul; 40(1):1-12. PubMed ID: 9920528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Active drug release systems: current status, applications and perspectives.
    Kiryukhin MV
    Curr Opin Pharmacol; 2014 Oct; 18():69-75. PubMed ID: 25265597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sustained and controlled release of neuroactive substances in the CNS by encapsulation into implantable polymers.
    Peterson GM
    Neurobiol Aging; 1989; 10(5):639-40; discussion 648-50. PubMed ID: 2812244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Controlled drug release from implantable matrices based on hydrophobic polymers.
    Di Colo G
    Biomaterials; 1992; 13(12):850-6. PubMed ID: 1457678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug Release Kinetics from Nondegradable Hydrophobic Polymers Can Be Modulated and Predicted by the Glass Transition Temperature.
    Qian J; Berkland C
    Adv Healthc Mater; 2021 Jun; 10(12):e2100015. PubMed ID: 33987963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.